HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis.

AbstractBACKGROUND:
High incidence of venous thromboembolic complications in coronavirus disease 2019 (COVID-19) patients was noted recently.
OBJECTIVE:
This study aimed to explore the factors associated with prevalence of venous thromboembolism (VTE) in COVID-19 patients.
METHODS:
A literature search was conducted in several online databases. Fixed effects meta-analysis was performed for the factors associated with prevalence of VTE in COVID-19 patients.
RESULTS:
A total of 39 studies were analysed in this analysis. The incidence of pulmonary embolism and VTE in severe COVID-19 patients were 17% (95% CI, 13-21%) and 42% (95% CI, 25-60%), respectively. VTE were more common among individuals with COVID-19 of advance age. Male COVID-19 patients are more likely to experience VTE. Higher levels of white blood cell (WBC; WMD = 1.34 × 109/L; 95% CI, 0.84-1.84 × 109/L), D-dimer (WMD = 4.21 μg/ml; 95% CI, 3.77-4.66 μg/ml), activated partial thromboplastin time (APTT; WMD = 2.03 s; 95% CI, 0.83-3.24 s), fibrinogen (WMD = 0.49 μg/ml; 95% CI, 0.18-0.79 g/L) and C-reactive protein (CRP; WMD = 21.89 mg/L; 95% CI, 11.44-32.34 mg/L) were commonly noted in COVID-19 patients with VTE. Patients with lower level of lymphocyte (WMD = -0.15 × 109/L; 95% CI, -0.23--0.07 × 109/L) was at high risk of developing VTE. The incidence of severe condition (OR = 2.66; 95% CI, 1.95-3.62) was more likely to occur among COVID-19 patients who developed VTE.
CONCLUSION:
VTE is a common complication in severe COVID-19 patients and thromboembolic events are also associated with adverse outcomes.
AuthorsTing Wu, Zhihong Zuo, Deyi Yang, Xuan Luo, Liping Jiang, Zanxian Xia, Xiaojuan Xiao, Jing Liu, Mao Ye, Meichun Deng
JournalAge and ageing (Age Ageing) Vol. 50 Issue 2 Pg. 284-293 (02 26 2021) ISSN: 1468-2834 [Electronic] England
PMID33201226 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
Copyright© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: [email protected].
Topics
  • Aged
  • Blood Coagulation Tests (methods)
  • COVID-19 (blood, complications, diagnosis)
  • Humans
  • Risk Factors
  • SARS-CoV-2
  • Severity of Illness Index
  • Venous Thromboembolism (diagnosis, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: